News
Viking Therapeutics ' ( VKTX 0.28%) shares could rise over the next year by as much as 165% at the midpoint according to some ...
Regeneron topped Wall Street estimates for second-quarter results on Friday, on robust demand for its blockbuster eczema drug ...
President Donald Trump just sent letters to heads of 17 major pharmaceutical companies pushing them to drop drug prices in ...
Two presentations discussed the significant care disruptions when there are copay assistance shortages, with patients ...
Q2 2025 Earnings Call Transcript August 1, 2025 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results